Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-03CORT3Corcept Therapeutics Form 3: Initial Beneficial Ownership Report for New President, Oncology Roberto VieiraMEDIUM
On September 3, 2026, Corcept Therapeutics Incorporated filed a Form 3 initial statement of beneficial ownership on behalf of Roberto Vieira, who serves as President, Oncology. The filing reports his direct beneficial ownership of 4,068 shares of common stock, which includes shares underlying unvested restricted stock ...
Large CapBiotechnology
2026-09-03ATHA3Form 3 Filing for LeonaBio, Inc. - Ownership ChangeMEDIUM
This filing reports a change in beneficial ownership for David J. Portman, with LeonaBio, Inc. (LONA). Mr. Portman, identified by CIK 0002126186, is filing as a 10% owner. The filing specifically addresses a warrant held by Sermonix Pharmaceuticals, Inc., where Mr. Portman serves as CEO. While Mr. Portman has voting co...
Nano CapBiotechnology